1/25/2012
Intezyne Scientists Gain Cover Art for the Journal of Polymer Chemistry
6/14/2011
Intezyne Featured in 83 Degrees
1/25/2011
Intezyne Named Company 'On The Rise' by Drug Development & Delivery Magazine
7/19/2010
Intezyne CEO Featured in Drug Delivery Technology
4/22/2010
Intezyne Receives Intent-to-Grant Notice from the European Patent Office

Targeted Drug Delivery

Intezyne is a biotechnology corporation developing synthetic polymers for targeted drug delivery. For more information, please contact us at info@intezyne.com, and click on the following link to learn more about Our Technology.

Intezyne is an innovative and dynamic company employing a unique approach to solving the most important and complex problems associated with targeted drug delivery. By integrating the fields of organic and polymer chemistry, polymer physics, materials science, biochemistry, and biology, Intezyne is well-positioned to develop new polymeric biomaterials and drug delivery vehicles that will impact the millions of people worldwide who suffer from disease.

In contrast to the use of off-the-shelf polymers to develop "new" delivery technologies, Intezyne looks to design and chemically tailor novel polymers to address key problems in drug delivery. This fundamentally different strategy has led to the development of new heterobifunctional poly(ethylene glycol) (PEG) reagents and the IVECT™ drug delivery platform, a versatile system that addresses the diverse requirements for advanced drug delivery.
COMPANY PROFILE | OUR TECHNOLOGY | NEWS | INVESTORS | CONTACT US | INTEZYNE HOME
Intezyne © 2012